Security key
52635N103
LENZ Therapeutics, Inc. - Common Stock (LENZ)
CUSIP: 52635N103
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock
- Shares outstanding
- 31,105,155
- Total 13F shares
- 21,072,237
- Share change
- +1,165,262
- Total reported value
- $541,761,121
- Reported price per share
- $25.71
- Number of holders
- 105
- Value change
- +$29,092,976
- Number of buys
- 53
- Number of sells
- 38
Security identity
Holder snapshot
Report period
Q1 2025
Institutions
105
Top holders
10
LENZ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
LENZ Therapeutics, Inc. SEC filings
LENZ Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 52635N103
Recent filing periods:
Ownership snapshot
Top reported holders of LENZ - LENZ Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
RA CAPITAL MANAGEMENT, L.P.
13D/G signal
—
Evidence rows
15
Latest as of
31 Dec 2024
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Rank 1 holder
RA CAPITAL MANAGEMENT, L.P.
13F
- Ownership
- 13%
- Position
- $120.64M
Rank 2 holder
Alpha Wave Global, LP
13F
- Ownership
- 12%
- Position
- $104.28M
Rank 3 holder
VANGUARD GROUP INC
13F
- Ownership
- 3.8%
- Position
- $34.02M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
13%
|
$120,642,620
4,178,823 shares
|
— | 31 Dec 2024 |
| Alpha Wave Global, LP |
13F
Company
|
12%
|
$104,284,532
3,612,211 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.8%
|
$34,021,765
1,178,447 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
3.7%
|
$33,362,894
1,155,625 shares
|
— | 31 Dec 2024 |
| 72 Investment Holdings, LLC |
13F
Company
|
3.3%
|
$29,382,471
1,017,751 shares
|
— | 31 Dec 2024 |
| Samsara BioCapital, LLC |
13F
Company
|
3.2%
|
$28,494,141
986,981 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
105
Shares
21,072,237
Rows available
105
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
94
Q1 2025 holders
105
Holder diff
11
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend